---
title: "Dibromotyrosine - Hyperthyroidism"
sidebar: mydoc_sidebar
permalink: db07637-mesh-d006980-1.html
toc: false 
---


Path ID: `DB07637_MESH_D006980_1`
{% include image.html url="images/db07637-mesh-d006980-1.png" file="db07637-mesh-d006980-1.png" alt="db07637-mesh-d006980-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DB07637 | dibromotyrosine | Drug |
| GO:0006590 | thyroid hormone generation | BiologicalProcess |
| MESH:D006980 | Hyperthyroidism | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dibromotyrosine | NEGATIVELY REGULATES | Thyroid Hormone Generation |
| Thyroid Hormone Generation | POSITIVELY CORRELATED WITH | Hyperthyroidism |
|---------|-----------|---------|

Comment: There is very little information on this drug; it's known that is part of a class of antithyroid preparations. It's in Phase 0 of clinical trials, aka research/experimental phase as per Jun 2021.

Reference: 
  - [https://go.drugbank.com/drugs/DB07637](https://go.drugbank.com/drugs/DB07637)
  - [https://en.wikipedia.org/wiki/Dibromotyrosine](https://en.wikipedia.org/wiki/Dibromotyrosine)
  - [https://en.wikipedia.org/wiki/Antithyroid_agent#Mechanism_of_action](https://en.wikipedia.org/wiki/Antithyroid_agent#Mechanism_of_action)
